Share

    


In This Section

Advisory Committee

Multi-Cancer Early Detection Advisory Committee
Westgate_Candace-100x100
Candace Westgate, DO
Chief of Staff Elect and Director of Adventist Health Early All-Around Detection (AHEAD)
Adventist Health
St. Helena, CA

Candace Westgate, DO, is the chief of staff elect at Adventist Health and the founder and director of the Adventist Health Early All-Around Detection (AHEAD) program, a population health cancer risk assessment and prevention program focused on the management of familial and hereditary cancer risk for patients and their families. Cancer risk assessment and prevention strongly aligns with her philosophy of practice and she believes in partnering with and empowering patients on their journey to find health.

Dr. Westgate previously served as chief of surgery and medical director of Women and Infant Services for Adventist Health. She is board certified in obstetrics and gynecology, completed her certification in women’s genomics counseling from the American College of Obstetricians and Gynecologists (ACOG) and was a graduate of the 2018 City of Hope intensive course in hereditary cancer risk assessment. She holds additional certifications in advanced laparoscopy, menopausal management, and cancer genetics.

Dr. Westgate earned her medical degree from A.T. Still University’s College of Osteopathic Medicine and completed her residency in obstetrics and gynecology at Georgetown University Hospital in Washington DC, where she served as chief resident in her final year. She earned her master’s degree in public health from Tulane University, where her focus was on program management and maternal and child health, and her bachelor of science degree from Oral Roberts University.

State of Multi-Cancer Early Detection Advisory Committee
Nabavizadeh_Nima-100x100
Nima Nabavizadeh, MD
Director of the Radiation Oncology Residency Program
Cancer Early Detection Clinical Research at CEDAR
Portland, OR

Dr. Nima Nabavizadeh MD is Associate Professor of radiation medicine, Program Director of the Radiation Oncology Residency Program for the Department of Radiation Medicine and Director of the Cancer Early Detection Clinical Research at CEDAR. Through partnerships with many biotech companies, Dr. Nabavizadeh studies the testing and implementation of novel tests for the early development of cancers. Clinically, he specializes in gastrointestinal oncology and lymphoma/hematologic malignancies, but treats all types of cancer. Dr. Nabavizadeh earned an undergraduate degree in Mechanical Engineering at the University of Oklahoma, where he also went to medical school. He completed his residency training in radiation oncology at OHSU.

ODonnell_Elizabeth-100x100
Elizabeth K. O'Donnell, MD
Director, Multi-Cancer Early Detection Clinic
Centers for Early Detection and Interception at the Dana-Farber Cancer Institute
Boston, MA

Dr. O’Donnell is a medical oncologist and the Director of the Multi-Cancer Early Detection Clinic in the Centers for Early Detection and Interception at the Dana-Farber Cancer Institute. She is an Assistant Professor of Medicine at Harvard Medical School and a physician-researcher in the Plasma Cell Disorder Center. She graduated from Vanderbilt Medical School and completed her residency at Beth Israel Deaconess Medical Center where she spent an additional year as a chief resident. She completed her fellowship in hematology and oncology at the Dana-Farber Cancer Institute. Her research focuses on early detection of cancer and therapeutic and lifestyle interventions for the treatment of plasma cell dyscrasias.

Our Partner

Cancer Support Community Logo